Editorial

Epidural morphine for post-Caesarean analgesia
W,D.R. Writer MB ~ARCS ~CrC
"Among the remedies which it has pleased A hnighty God to give to man to relieve his sufferings, none is so universal and so efficacious as opium." Thomas Sydenham (1627-82) London, England, 1680
More than 300 years after his death, Sydenham's observations remain true. Synthetic analgesics come and go, but none endures like the natural alkaloid, opium, first used by Theophrastus, in the 3rd Century BC. ~ Morphine (the principal alkaloid of opium) has no superior for postoperative pain relief, and remains the gold standard against which other analgesics must be judged. However, in contemporary times, the preferred route of morphine's administration provokes controversy. A succession of "neuraxial chauvinists" seeks to emphasize the virtues of epidural (EM) or intrathecal morphine for postoperative pain, while others opt for intravenous or the timeworn, if ineffective, intramuscular administration.
In this issue, Fuller and colleagues review their clinical experience of almost 5000 EM subjects following Caesarean section. 2 The benefits in post-Caesarean mothers are already well documented,3-7 but this is the fin'st extensive Canadian report. Epidural morphine gave prolonged, effective analgesia for a mean of 23 hr, in doses from 2-5 mg. Eleven per cent of subjects needed no other pain relief for 48 hr (reflecting the experience of another large study, in which 16 per cent required no further analgesia before discharge, and oral analgesics sufficed as the only additional pain relief in 44 per cent), s Despite the cumulative clinical experience, which must number in excess of 10,000 women in Canada, some anaesthetists continue to question the safety and desirability ofEM, and prefer shorter-acting agents such as fentanyl, or alternative routes of delivery, such as intravenous PCA. They point to the high incidence of side-effects, most notably pruritus, and the "most feared ''9 complication of EMdelayed respiratory depression.
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Are these fears realistic, or can we safely administer EM to post-Caesarean women, subsequently nursed on the routine postpartum floor, with the less intense observation that connotes? How severe is the morbidity associated with EM in this group of subjects'? Fuller reported pruritus in 60 per cent, nausea and vomiting in 40 per cent, dizziness in 10 per cent, and bradypnoea in 0.25 per cent.
Unquestionably, neuraxial morphine greatly increases the occurrence of pruritus. This sometimes troublesome (but never dangerous) side-effect may occur in up to 90 per cent of obstetric subjects, although the reported incidence varies widely, to Harrison et al. 9 noted pruritus in 72 per cent of women, but only 45 per cent required treatment. After PCA or IM morphine, the incidence decreased to 38 and 17 per cent respectively, with a smaller number requiring treatment. Pruritus appears to be enkephalin-mediated, and may represent a rudimentary itch reflex, with an afferent spinal arc. It responds poorly to conventional antipruritics, but small, incremental doses of IV naloxone, 0.04 mg, abolish itching, while leaving the duration of pain relief unaffected. 9 Some workers alternatively administer prophylactic IV naloxone, or IM nalbuphine.
In 1986, two Canadian university departments independently reported recurrent oral herpes simplex lesions (HSV I) in parturients following EM. TM In a later prospective study, Crone et al. 13 suggested the incidence was as high as nine per cent. In further work, having tried to eliminate confounding variables, such as the use of epinephrine and different local anaesthetics, Crone observed that almost 15 per cent of women developed cold sores, compared with none after IM morphine. J4 Facial pruritus occurred in all who subsequently experienced recurrent herpes, and presumably provoked its onset. Fuller identified HSV I lesions in only 3.5 .per cent of subjects, although under-reporting may have occurred in his retrospective survey. Since pruritus appears to be dose-related, and a prerequisite for recurrent herpes simplex, Fuller's recommendation that we employ the lowest effective dose of morphine (3 mg) seems appropriate.
What, then, of respiratory depression'? The Vancouver group allowed patients to return to the postpartum floor, for hourly nursing observations, after discharge from the Recovery Room. This practice pertains in other Canadian and American centres, although additional respiratory monitoring, such as CO2 sensing, pulse oximetry, or measurement of chest impedance may complement the postoperative routine, t5.~6 However, as Fuller emphasizes, in all studies reported to date routine nursing observations have sufficed to document respiratory depression. Leicht et al. s identified one patient with severe bradypnoea out of 1,000 subjects, following 5 mg EM. At the slowest respiratory rate (4 breaths, min -t) she had severe respiratory acidosis (pH 7.08, PaCO2, 76 mmHg, PaO2 40 mmHg) which responded promptly to naloxone and 02. The decline in respiratory rate occurred gradually and the authors speculated that earlier intervention, when the respiratory rate decreased to 10 or 9 breaths.min, -~, would have avoided the severe acidosis.
Brose et al..6 used pulse oximetry to detect hypoxaemia in mothers following epidural, PCA and IM morphine. Desaturation occurred with all three regimens, but EM subjects experienced more severe changes, leading the authors to recommend intensive postoperative surveillance. In contrast, Ostman et al. 17 (in only six subjects) found that women in late pregnancy spent a considerable time with SaO2 91-95 per cent, while sleeping, on the night before EM, an important observation missing from Brose's study. No apparent worsening of this desaturation occurred following EM. In short, mothers who receive morphine, by whatever route, may experience transient desaturation, but there is no evidence to indicate that these episodes are more severe than encountered in sleep.
The above findings suggest that clinical observation will suffice in the detection of the infrequent severe bradypnoea. In the light of the accumulated clinical and research experience, I believe women after Caesarean section can safely receive EM, and be transferred to a postpartum floor. However, all units must develop a careful monitoring protocol, which permits detection of bradypnoea, and unexpected sedation. Ready et al.tS describe such a protocol. Should bradypnoea or somnolence occur, personnel able to assess the severity of the respiratory depression, and competent to administer intravenous naloxone, must be immediately available.
If we are to remain faithful to the memory and tradition of Thomas Sydenham, we must recognize morphine's unchallenged and universal efficacy, while bringing our knowledge and research to bear on the route of its administration. A single epidural injection of 3 mg, followed by appropriate nursing observations, at least hourly for 12 hr, is a cost-effective beneficial analgesic regimen in women after Caesarean section. The same cannot yet be said for PCA morphine, which may involve significant capital investment, but offers less pain relief.
Fuller's paper makes an additional and very important point. The physiological changes of pregnancy include increased alveolar ventilation and an enhanced sensitivity to CO2. Pregnant women appear to have a very low risk of respiratory depression. Although we lack definitive evidence, we may hypothesise that the respiratory changes of pregnancy confer some protection against narcoticinduced hypopnoea. Caesarean section subjects, therefore, constitute a "special case. ''~9 Non-pregnant individuals, in contrast, may show marked sensitivity to EM. Ces craintes sont-elles rEalistes et peut-on administrer avec sEcuritE la morphine Epidurale en post-cEsarienne chez les femmes qui doivent subsEquemment ~tre envoyEes ~t I'Etage sous une surveillance moins intense qu'il est nEcessaire ? Combien sEv/~re est la morbidit6 associEe avec la morphine Epidurale dans ce groupe de sujets ? Fuller rapporte une incidence de prurit de 60 pour cent, nausEe et vomissement de 40 pour cent, Etourdissement de 10 pour cent et bradypnEe de 0.25 pour cent.
Sans doute, la morphine neuraxiale augmente 6normE-merit rincidence de prurit. Cet effet secondaire parfois troublant (mais jamais dangereux) peut survenir jusqu'b. 90 pour cent des sujets obstEtricaux mEme si rincidence rapportEe varie EnormEment. ~o Harrison et al. 9 ont note du prurit chez 72 pour cent de femmes, mais seulement 45 pour cent ont requis un traitement. Apr~:s PCA ou l'administration de morphine intramusculaire, I'incidence diminua ~ 38 et 17 pour cent respectivement, avec un plus petit nombre requErant un traitement. Le prurit appara~t initiE par l'enkephalin et peut representer un r~flexe de grattage rudimentaire avec un arc spinal r~flexe. II rEpond faiblement aux antipruritiques conventionnels et des petites doses intraveineuses de naloxane, 0.04 mg, abolissent le grattage mais prEservent la durEe inaffectEe de la douleur. 9 D'autres chercheurs administrent alternativement d'une faqon prophylactique le naIoxane intraveineux ou la nalbuphine intramusculaire.
En 1986, deux dEpartemenls universitaires Canadiens, indEpendamment, ont rapportE la recurrence de lesions d'herp~:s simplex orales (HSV 1) chez les parturientes apr~s morphine Epidurale. i1,12 Plus tard, dans une Etude prospective, Crone et al. 13 ont suggErE que I'incidence Etait aussi haute que neuf pour cent. D'autres Etudes ont tentE d'Eliminer les variables qui am~nent ~ la confusion comme rutilisation de I'EpinEphrine et des agents anesthEsiques Iocaux diffErents, Crone observa qu'~ peu pros 15 pour cent des femmes ont dEveloppE des lesions d'herp/~s simplex orales comparativement h aucune apr~s radministration de morphine intramusculaire. 14 Du prurit facial est survenu chez toutes les femmes qui ont subsEquemment eu une recurrence des lesions d'herp~:s et prEsumEment ont provoquE son Etablissement. Fuller a identifiE des lesions HSV ! chez seulement 3.5 pour cent des sujets m~me si une sous-estimation rapponEe peut ~tre survenue dans cette Etude retrospective. Etant donne que le prurit apparait en relation avec la dose, et serait un prE-requis pour la recurrence de l'herp~:s simplex, Fuller recommande d'employer la plus basse dose efficace de morphine (3 mg).
Qu'en est-il pour la depression respiratoire ? Le groupe de Vancouver a pennis aux patientes de retourner ~ rEtage du postpartum pour une surveillance aux heures apr~:s congE de la salle de rEveil. Cetle pratique tient dans d'autres centres Canadiens et AmEricains mEme si la surveillance respiratoire additionelle comme la capnomEtrie et I'oxymEtrie ou la mesure de I'impEdance thoracique peut complEmenter la routine postopEratoire.~5'~6 Cependant, comme Fuller insiste, dans toutes les Etudes rapportEes ~ date, la surveillance de routine Etait suffisante pour documenter une depression respiratoire. Leicht et al. 8 ont identifiE une patiente avec une bradypnEe sEv~:re sur !,000 sujets apr~s 5 mg de morphine Epidurale. La frEquence respiratoire la plus basse (4 respirations/rain -I) a crEE une acidose respiratoire severe (pH 7.08, PaCO2, 76 mmHg, PaO2 40 mmHg) qui a rEpondu rapidement/l la naloxane et roxyg/me. La diminution de la frEquence respiratoire est survenue graduellement et les auteurs spEculent une intervention plus prEcoce lorsque la frEquence respiratoire diminue ~ 10 ou 9 respirations/ min -t, aurait EvitE I'acidose severe.
Brose et al. 16 ont utilisE roxymEtrie afin de detecter rhypoxEmie chez la m~re apr~,s I'administration de morphine par voie Epidurale, PCA et IM. La dEsaturation est survenue avec les trois regimens, mais les sujets ayant eu la morphine Epidurale ont dEmontrE les alterations les plus sEv~res conduisant les auteurs b. recommander une surveillance postopEratoire intensive. Par contre, Ostman et coll~gues ~7 (chez seulement 6 sujets) ant trouv6 que les femmes en fin de grossesse se promenaient avec des SaO2 entre 91-95 pour cent, Iors du sommeil, et la veille de l'administration 6pidurale de morphine, une observation importante que Brose a manqu6 dans son 6rude. Aucune d6t6rioration de saturation n'est survenue apr~:s administration de morphine 6pidurale. En r6sum6, les m6res ayant re~ju de la morphine par n'importe quelle voie peuvent d6montrer une d6saturation transitoire mais il n'y a aucune 6vidence indiquant que ces 6pisodes sont plus s6v~res que ceux encourus Iors du sommeil.
Les trouvailles sus-mentionn6es sugg~rent que I'observation clinique sera suffisante afin de d6tecter cette bradypn6e s6v~re rare. A la lumi6re des donn6es cliniques accumul6es et de la recherche exp6rimentale, je pense que les femmes post-c6sariennes peuvent recevoir avec s6cu-rit6 de la morphine en ~pidurale et peuvent ~tre transf~r6s sur 1'6tage en postpartum. Cependant, routes les unit6s doivent d6velopper un protocole de surveillance 6troite qui permet la d6tection de la bradypn6e et la s6dation non-pr6vue. Ready et al. ts ant d6crit un tel protocole. Si la bradypn6e et la somnolence surviennent, du personnel capable d'6valuer la s6v6rit6 de la d6pression respiratoire, et comp6tent pour administrer du naloxone par vole intraveineuse, dolt ~tre imm~diatemenl disponible.
Si l'on doit 6tre fiddle ~t la m6moire et b. la tradition de Thomas Sydenham, on doit reconnaitre l'efficacit6 universelle et incontest6e de la morphine et en m6me temps orienter nos connaissances et has recherches sur les voies de son administration. Une injection 6pidurale unique de 3 mg, suivie d'une surveillance appropri6e aux heures pour 12 heures, repr6sente un moyen analg6sique b6n6-fique et peu dispendieux pour les femmes post-c6sariennes. On ne peut dire la m6me chose pour la morphine PCA qui implique un investissement significatif mais offre mains de soulagement de douleur. L'6tude de Fuller souligne un point additionnel tr~s important. Les changements physiologiques de la grossesse incluent une augmentation de la ventilation alv6olaire et une plus grande sensibilit6 ,~ la CO2. Les femmes enceintes d6montrent apparemment un risque tr6s faible de d6pression respiratoire. M~me si I'on manque d'6vi-dence d6finitive, on peul soulever I'hypoth~:se que les changements respiratoires Iors de la grossesse am6nent une protection contre I'hypopn6e induite par les narcotiques. Les sujets devant subir une c6sarienne, ainsi, constituent ~ un cas sp6cial ~,>.19 Les femmes nonenceintes, par contre, peuvent d6montrer une sensibilit6 :~ la morphine en injection 6pidurale. Etches et al. ,9 mettent I'emphase que I'utilisation des opiac6s par voie 6pidurale dans un environnement non-obstEtrical requi6re une surveillance de la fr~quence respiratoire, de la somnolence et possiblement des mesures additionnelles comme des moniteurs d'apn6e ou des saturom~tres. Les trouvailles de Fuller ne doivent pas 6tre extrapol6es ~ la population chirurgicale en g6n6ral et I'on ne dolt pas permettre h notre enthousiasme pour la morphine neuraxiale chez les femmes enceintes d'6tre d6chain6es et de s'6tendre aux soins postop6ratoires des vieilles femmes en d6clin.
